The main objective of this proposal is to demonstrate that the medial temporal lobe (hippocampus and parahippocampal gyrus) is specifically vulnerable to the effects of normal aging and is of fundamental importance in predicting age-related memory changes. Our preliminary studies have contributed to a greater understanding of the relationship between hippocampal integrity and cognitive functioning. We previously developed and replicated a CT diagnostic marker that predicts with 91% accuracy which non-demented, but minimally impaired individuals are likely to develop symptoms of Alzheimer's Disease (AD) within a 3 to 4-year interval. This subjectively assessed marker relies on increased CSF accumulation within the peri-hippocampal fissures as an indirect index of hippocampal atrophy and is referred to as HCSF. Our neuropathological studies of the hippocampal region in AD have validated the observation of HCSF as a marker of hippocampal atrophy. Preliminary MR volume studies have revealed both the anatomy and a potential anatomic specificity for these early hippocampal changes. In normal aging, we have shown that HCSF is associated with reduced memory performance. We now propose a 5 year NR project to collect longitudinal data on the clinical risks associated with direct parenchymal measures of hippocampal volume reduction (HVOL) among non-demented elderly. Salient hypotheses to be tested include: (l) HVOL is predictive of progressive memory changes in normal elderly, (2) HVOL predicts future lateral temporal lobe atrophy and (3) HVOL combined with lateral temporal lobe atrophy are necessary for the expression of the cognitive symptoms of AD. We propose a 5-year longitudinal study on 2 elderly groups, each n=100. These groups will be selected to represent the full range of cognitive functioning associated with normal aging as well as the full range of HVOL seen in non-demented elderly individuals. We will use a gradient echo MR procedure with good gray-white contrast in order to improve our current in vivo anatomic identification. The results from this study will improve our knowledge of the hippocampus and the prediction of cognitive decline in aging.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
1R01AG012101-01
Application #
3123800
Study Section
Clinical Neuroscience Review Committee (CNR)
Project Start
1993-09-30
Project End
1998-08-31
Budget Start
1993-09-30
Budget End
1994-08-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
New York University
Department
Type
Schools of Medicine
DUNS #
004514360
City
New York
State
NY
Country
United States
Zip Code
10012
Mattsson, Niklas; Groot, Colin; Jansen, Willemijn J et al. (2018) Prevalence of the apolipoprotein E ?4 allele in amyloid ? positive subjects across the spectrum of Alzheimer's disease. Alzheimers Dement 14:913-924
Fortea, Juan; Carmona-Iragui, María; Benejam, Bessy et al. (2018) Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Lancet Neurol 17:860-869
Sharma, Ram A; Varga, Andrew W; Bubu, Omonigho M et al. (2018) Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study. Am J Respir Crit Care Med 197:933-943
Solesio, María E; Peixoto, Pablo M; Debure, Ludovic et al. (2018) Carbonic anhydrase inhibition selectively prevents amyloid ? neurovascular mitochondrial toxicity. Aging Cell :e12787
Butler, Tracy; Harvey, Patrick; Deshpande, Anup et al. (2018) Basal forebrain septal nuclei are enlarged in healthy subjects prior to the development of Alzheimer's disease. Neurobiol Aging 65:201-205
Snyder, Heather M; Carare, Roxana O; DeKosky, Steven T et al. (2018) Military-related risk factors for dementia. Alzheimers Dement 14:1651-1662
Illán-Gala, Ignacio; Pegueroles, Jordi; Montal, Victor et al. (2018) Challenges associated with biomarker-based classification systems for Alzheimer's disease. Alzheimers Dement (Amst) 10:346-357
Ramos-Cejudo, Jaime; Wisniewski, Thomas; Marmar, Charles et al. (2018) Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link. EBioMedicine 28:21-30
Lewczuk, Piotr; Riederer, Peter; O'Bryant, Sid E et al. (2018) Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiatry 19:244-328
Chen, Jingyun; Li, Yi; Pirraglia, Elizabeth et al. (2018) Quantitative evaluation of tau PET tracers 18F-THK5351 and 18F-AV-1451 in Alzheimer's disease with standardized uptake value peak-alignment (SUVP) normalization. Eur J Nucl Med Mol Imaging 45:1596-1604

Showing the most recent 10 out of 183 publications